EUVIMEDEUVIMED entdecken
Crossref

From the Editor-in-Chief: The Beneficial "Spin-Out" Business Model

Keith L. Carson

BioProcessing Journal · 27.07.2026 · 3

DOI: 10.12665/j121.carson ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioProcessing Journal, online erschienen am 27.07.2026. Verfasst von Keith L. Carson.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Consistent with our well-established format, this issue contains a very interesting collection of technical articles. However, we have stepped outside our normal content with a manuscript on the successful implementation of a “spin-out” company that was formed to develop a highly specialized technology. I’m hoping that this article by Dr. Charlotte Dyring (ExpreS2ion Biotechnologies) will provide inspiration to others who have envisioned a similar business model, plus trace a roadmap for organizations which have discovered that mergers and acquisitions aren’t giving them the products or sustainable growth they really need...

Zitieren

APA

Carson, K. L. (2026). From the Editor-in-Chief: The Beneficial "Spin-Out" Business Model. BioProcessing Journal, 3. https://doi.org/10.12665/j121.carson

Vancouver

Carson KL. From the Editor-in-Chief: The Beneficial "Spin-Out" Business Model. BioProcessing Journal. 2026:3. doi:10.12665/j121.carson

BibTeX
@article{Carson2026,
  author = {Carson, Keith L.},
  title = {From the Editor-in-Chief: The Beneficial "Spin-Out" Business Model},
  journal = {BioProcessing Journal},
  year = {2026},
  pages = {3},
  doi = {10.12665/j121.carson}
}
Kostenlos starten →